The Safety and Efficacy of Neoadjuvant Chemotherapy using Apatinib plus SOX in Local Advanced Gastric Cancer

Trial Profile

The Safety and Efficacy of Neoadjuvant Chemotherapy using Apatinib plus SOX in Local Advanced Gastric Cancer

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Dec 2016

At a glance

  • Drugs Apatinib (Primary) ; Oxaliplatin (Primary) ; Tegafur (Primary)
  • Indications Adenocarcinoma; Gastric cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top